The local medical sector is abuzz with the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist showing significant results in scientific trials for addressing obesity. This medication https://artybookmarks.com/story21582194/retatrutide-australia-australia-a-new-hope-for-weight-management